Home Equities Score ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful...

ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful first trial report

ASLAN Pharmaceuticals (NASDAQ: ASLN) moved upward an impressive 73.58% and has reached a share price of $7.69. ASLAN had previously closed at $4.43. This all happened in the pre-market Monday trading session.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Operational Biodata

Aslan Pharmaceuticals Ltd was founded in 2010. It is a biotech pharmaceutical company with headquarters in Singapore. ASLAN (NASDAQ: ASLN) specializes in clinical-stage immunology and oncology for the treatment of patients. Specifically, it has a focused-area-of-expertise in running test treatments for atopic dermatitis and small-molecule inhibitor that targets oncology.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

ASLAN Phase 1 Trial Successful!

The jump in the pre-market trade arose due to an announcement made today about a certain treatment called ASLAN004 which is a monoclonal therapy used essentially to treat atopic dermatitis and other immunology indications. The press-release that is referring to the scientific-specific terminology is highlighted here.

“positive interim unblinded data from the three dose cohorts of its ongoing randomized, double-blind patio placebo-controlled multiple ascending dose study of ASLAN004 for the treatment of moderate to severe atopic dermatitis.”

In laymen’s term what this string of scientific-pharmaceutical jargon means is that the monoclonal therapy ASLAN004 was run through several excessive tests where test-subjects were placed in the control group and placebo group, where the patients placed in the control group were given ASLAN dosage that showed efficacy compared to the group which was given placebo effect.

Biotech Penny Stock

The ASLAN pharmaceutical is a penny stock and penny stocks have a tumultuous reaction towards business cycles. When the stock market seems to be plummeting or breaking down, these biotech penny stocks tend to soar and they plunge when the market is rising. These penny stocks have an inverse relation with the fall & rise of the stock market because the factors they depend on are different.

Another factor that is really associated with the rise and decline of these biotech penny stocks is that pharmaceutical companies have clinical tests and trials that they run for different drugs and treatments. When news of the success of the treatment or (FDA) approval of the drug is verified then this news really soars up the prices of the stock as the sentiment around the stock becomes positive.

$18 million security purchase agreement

Investors also look forward to news of mergers, deals, business licensing, and approvals to determine the movement of the stock. On 25th February, ASLAN pharmaceuticals had announced the security purchase deal that it entered into through a private placement to Surveyor Capital and Vivo Capital, which are relatively new institutional investors. The agreement allows the acquiring and raising of $18 million gross proceeds resulting from the sale of its ordinary purchases.

The terms of the securities purchase agreement state that the company will issue 5,113,636 American Depository Shares at a price per share of $3.52 which is equivalent to the last closing price of the Company’s ADS.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Watch Out For Second Phase Trials

This interim data is from the ongoing study of the phase 1 clinical trial test which is very significantly positive news. However 1st phase also means that there are more phases to come which will determine the true authenticity and efficacy of the ASALN004, thus ASLAN (NASDAQ: ASLN) stock should be the biotech penny stock that investors need to keep a close eye on, this year. The pharmaceutical company plans on starting the 2b phase of the trials this year, which will be sooner now due to a successful first phase trial as compared to prolonged delay if the trials were unsuccessful.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Here is why MicroVision Inc. (MVIS) stock surged in the after-hours on Wednesday?

MicroVision Inc. (MVIS) shares surged 14.98% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $14.05 per share. In the...

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Related News

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

Alto Ingredients Inc. (ALTO) stock fall during pre-market trading. Here’s what you should know?

Alto Ingredients Inc. (NASDAQ: ALTO) stock gained by 5.99% at last close whereas the ALTO stock-price plunge by 9.89% in the pre-market trading session....

Cuentas Inc. (CUEN) stock rises during after-hour trading, given no current update.

Cuentas Inc. (NASDAQ: CUEN) stock declined by 4.68% at last close whereas the CUEN stock price gains by 2.6% in the after-market. Cuentas is...

Why did Applied DNA Sciences Inc. (APDN) stock face headwinds in the after-hours on Tuesday?

Applied DNA Sciences Inc. (APDN) shares lost 3.82% in after-hours on Tuesday, August 03, 2021, and closed the daily trading at $6.55 per share....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam